Antimetabolites: all 7,305 studies that test it
Page 37 of 74. Open to participants first (1,098), then studies with results posted, then the rest; newest registration first within each.
- Cetuximab Plus Capecitabine as Maintenance Treatment in RAS and BRAF wt Metastatic Colorectal CancerActive, not recruitingNCT04262635Phase 3
- Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS TrialActive, not recruitingNCT04259944Phase 2
- Neoadjuvant Chomotherapy With Paclitaxel-albumin and S-1 for Advanced Gastric CancerStatus unknownNCT04258657Phase 2
- Camrelizumab in Combination With Apatinib Mesylate, Paclitaxel-albumin and S-1 for Translational Treatment of Gastric CancerStatus unknownNCT04258644Phase 2
- A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel AdenocarcinomaActive, not recruitingNCT04257461Phase 3
- Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic CancerCompletedNCT04257448Phase 1/2
- A Study of Postoperative Adjuvant Chemotherapy for Upper Urinary Urothelial Carcinoma With Lymphovascular InvasionStatus unknownNCT04255771Phase 3
- Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AMLStatus unknownNCT04254640Phase 2
- Decitabine Treatment in HPV-Induced Anogenital and Head and Neck Cancer Patients After Radiotherapy or as Novel Late SalvageTerminatedNCT04252248Phase 1
- Study of Azacitidine Combined With Homoharringtonie Based Regimens in AMLStatus unknownNCT04248595Phase 2
- Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the BodyActive, not recruitingNCT04248452Phase 3
- Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer.CompletedNCT04247165Phase 1/2
- Short RT Versus RCT,Followed by Chemo and Organ Preservation for Interm and High-risk Rectal Cancer PatientsActive, not recruitingNCT04246684Phase 3
- Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of HER2-positive Metastatic Breast CancerStatus unknownNCT04246502Phase 2
- A Study of Cetuximab Plus Raltitrexed for Maintenance Treatment in Advanced Colorectal CancerStatus unknownNCT04241731Phase 2
- A Study of Cusatuzumab Plus Azacitidine in Japanese Participants With Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Who Are Not Candidates for Intensive TreatmentCompletedNCT04241549Phase 1
- Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive VitiligoCompletedNCT04237103Phase 2
- Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has SpreadActive, not recruitingNCT04233866Phase 2
- Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid LeukemiaCompletedNCT04230239Phase 2
- A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal CancerStatus unknownNCT04227041Phase 1/2
- Trial of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, S-1 Followed by Surgery and Adjuvant Durvalumab Plus S-1 Chemotherapy in Potentially Resectable MMR Proficient Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT04221555Phase 2
- Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade GliomaWithdrawnNCT04220892Early Phase 1
- Trial Testing Safety of IL-21 NK Cells for Induction of R/R AMLCompletedNCT04220684Phase 1
- Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin LymphomaWithdrawnNCT04220008Phase 2
- A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCTActive, not recruitingNCT04217278Phase 2/3
- Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic CancerStatus unknownNCT04216758Phase 2
- Low-dose AZA Combined With Short Term CAG Derived Regimen as a Bridging Treatment in Patients With Advanced MDS Prior to Allo-HSCTStatus unknownNCT04216355Phase 2/3
- A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE TrialActive, not recruitingNCT04216290Phase 2
- CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell MalignanciesActive, not recruitingNCT04214886Phase 1
- Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host DiseaseActive, not recruitingNCT04212416Phase 1
- Camrelizumab With AC in Patients With Brain Metastases of Driven Gene-negative,NSCLCStatus unknownNCT04211090Phase 2
- Study of the Impact of DPD Activity on the Efficacy of CapecitabineActive, not recruitingNCT04198727Phase 2
- Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid NeoplasmsTerminatedNCT04196010Phase 1
- Improving the Safety of Fluoropyrimidine-based ChemotherapyStatus unknownNCT04194957Not applicable
- Testing the Addition of an Anti-cancer Drug, Navtemadlin, to the Usual Treatments (Cytarabine and Idarubicin) in Patients With Acute Myeloid LeukemiaActive, not recruitingNCT04190550Phase 1
- Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia Chromosome-Positive Acute Myeloid Leukemia or Myeloid Blast Phase or Accelerated Phase Chronic Myelogenous LeukemiaCompletedNCT04188405Phase 2
- Analysis of the Effectiveness of Neoadjuvant Chemotherapy in the Treatment of Colon Cancer Locally Advanced (ELECLA)Status unknownNCT04188158Phase 2
- A Study of CS1001 in Subjects With Esophageal Squamous Cell CarcinomaCompletedNCT04187352Phase 3
- Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG TreatmentActive, not recruitingNCT04179162Phase 1/2
- Clinical Comparative Study to Evaluate the Efficacy and Safety of Recombinant Anti-TNF-alpha Antibodies for InjectionStatus unknownNCT04178850Phase 3
- Cladribine Tablets After Treatment With Natalizumab (CLADRINA)Active, not recruitingNCT04178005Phase 4
- PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric CancerStatus unknownNCT04174339Not applicable
- A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With PlasmacytomaActive, not recruitingNCT04174196Phase 2
- Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic LeukemiaActive, not recruitingNCT04173988Early Phase 1
- Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCTCompletedNCT04173533Phase 3
- Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant MesotheliomaTerminatedNCT04173338Phase 1
- Pevonedistat, Azacitidine (or Decitabine), and Venetoclax for the Treatment of Patients With Acute Myelogenous LeukemiaTerminatedNCT04172844Phase 1
- NGS as the First-line Treatment in Advanced Biliary Tract CancerCompletedNCT04172402Phase 2
- LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment EfficacyActive, not recruitingNCT04166604Phase 2
- Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE StudyActive, not recruitingNCT04166318Phase 2
- Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder CancerActive, not recruitingNCT04164082Phase 2
- Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell LymphomaActive, not recruitingNCT04161248Early Phase 1
- Venetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic SyndromeTerminatedNCT04160052Phase 1/2
- Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic CancerSuspendedNCT04158635Phase 1
- Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast CancerActive, not recruitingNCT04158362Phase 3
- Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular LymphomaTerminatedNCT04156828Phase 1
- Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal CarcinomaActive, not recruitingNCT04156698Phase 2
- POF Versus FOLFOX Plus IP Paclitaxel in AGCStatus unknownNCT04155671Phase 2
- Autologous Transplant Targeted Against Crohn'sWithdrawnNCT04154735Phase 2
- A Study of Trifluridine/Tipiracil in Triple Negative Metastatic Breast CancerWithdrawnNCT04149444Phase 2
- Neoadjuvant POF in the Treatment of Locally Advanced Gastric CancerStatus unknownNCT04149015Phase 2
- Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast CancerStatus unknownNCT04143906Phase 2
- Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AMLCompletedNCT04139434Phase 1
- Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal CancerStatus unknownNCT04135313Phase 3
- Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal CancerStatus unknownNCT04134897Phase 3
- Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic SyndromeActive, not recruitingNCT04128748Phase 1/2
- Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant SettingActive, not recruitingNCT04128501Phase 2
- Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal TypeActive, not recruitingNCT04127227Phase 2
- Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCTStatus unknownNCT04123392Phase 2/3
- AraC for Newly Diagnosed Adult Langerhans Cell HistiocytosisStatus unknownNCT04121819Phase 2
- Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)CompletedNCT04121403Phase 3
- A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell LymphomaActive, not recruitingNCT04115631Phase 2
- Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic CancerActive, not recruitingNCT04115163Phase 2
- CPX-351 in Patients Treated for Higher-risk Myelodysplastic Syndromes Experiencing Hypomethylating Agent Failure.WithdrawnNCT04109690Phase 1/2
- Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell CarcinomaCompletedNCT04107103Phase 2
- Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed GlioblastomaWithdrawnNCT04105374Phase 2/3
- TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal CancerCompletedNCT04104139Phase 1
- Non-Viral TCR Gene TherapyWithdrawnNCT04102436Phase 2
- Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCTStatus unknownNCT04098653Phase 2/3
- T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR)WithdrawnNCT04093648Phase 1
- Effect of Food on the Pharmacokinetics of Decitabine/Tetrahydrouridine Combination Capsules in Healthy Adult SubjectsCompletedNCT04086238Phase 1
- Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60Status unknownNCT04083911Phase 3
- Study of TRIFLURIDINE/TIPIRACIL in Previously Treated CholangiocarcinomaTerminatedNCT04076761Phase 2
- A Study of Rivoceranib and Trifluridine/Tipiracil for Metastatic Colorectal Cancer (mCRC)TerminatedNCT04073615Phase 1
- EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR)Active, not recruitingNCT04072107Phase 2
- A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in TaiwanTerminatedNCT04070313Phase 2
- The Purpose of This Study is to Evaluate the Efficacy and Safety of Sintilimab in Combination With Xelox as Neoadjuvant Therapy for Patients With Resectable Locally Advanced Gastric or Gastroesophageal Adenocarcinoma.Status unknownNCT04065282Phase 2
- AZA + Venetoclax as Maintenance Therapy in Patients With AML in RemissionTerminatedNCT04062266Phase 2
- A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric CancerStatus unknownNCT04062058Phase 2
- Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Oligoblastic AMLCompletedNCT04061239Phase 2
- Paricalcitol Addition to Chemotherapy in Patients With Previously Untreated Metastatic Pancreatic Ductal AdenocarcinomaCompletedNCT04054362Phase 2
- Gemcitabine in Newly-Diagnosed Diffuse Midline GliomaWithdrawnNCT04051047Early Phase 1
- Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell CarcinomaStatus unknownNCT04049344Phase 2
- Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC)TerminatedNCT04046887Phase 1
- The Study of Gemcitabine Plus Nab-Paclitaxel in Combination With Pegvorhyaluronidase Alfa (PVHA; PEGPH20) and Pembrolizumab as Front-line Treatment for Metastatic Pancreatic Adenocarcinoma.WithdrawnNCT04045730Phase 2
- A Trial of CPX-351 Lower Intensity Therapy (LIT) Plus Venetoclax as First Line Treatment for Subjects With AMLCompletedNCT04038437Phase 1
- CRISPR (HPK1) Edited CD19-specific CAR-T Cells (XYF19 CAR-T Cells) for CD19+ Leukemia or Lymphoma.Status unknownNCT04037566Phase 1
- Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the ExtremitiesTerminatedNCT04037527Phase 1
- Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver MetastasesWithdrawnNCT04037241Phase 2/3
- Multimodal Cue Exposure Therapy for Smoking CessationWithdrawnNCT04035603Phase 2